ODT - Odonate Therapeutics...

Free cash flow build up of Odonate Therapeutics, Inc.(ODT), Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of can

photo-url-https://financialmodelingprep.com/image-stock/ODT.jpg

Odonate Therapeutics, Inc.

ODT

NASDAQ

Inactive Equity

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.

1.12 USD

-0.04999995 (-4.46%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Operating Data Balance Sheet Free Cash Flow Free Cash Flow Buildup Terminal Value Intrinsic Value WACC

FMP

Home Terms of Service Privacy Policy Blog Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.